The FDA will host a public meeting on April 21 to further engage with the medical device industry on “assessing changes in medical device risk as quality and safety situations arise in the postmarket setting” according to an article from InsideMedicalDevices.com. For more on this meeting, please visit: http://www.insidemedicaldevices.com/2015/03/23/fda-is-examining-device-risk-assessments-in-postmarket-settings/
